Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem Lett ; 17(4): 874-8, 2007 Feb 15.
Article in English | MEDLINE | ID: mdl-17234405

ABSTRACT

The optimization of potent MCHr1 antagonist 1 with respect to improving its in vitro profile by replacement of the 3,4-methylenedioxy phenyl (piperonyl) moiety led to the discovery of 19, a compound that showed excellent MCHr1 binding and functional potencies in addition to possessing superior hERG separation, CYP3A4 profile, and receptor cross-reactivity profiles.


Subject(s)
Piperidines/chemical synthesis , Piperidines/pharmacology , Receptors, Somatostatin/antagonists & inhibitors , Alkylation , Animals , Chemical Phenomena , Chemistry, Physical , Chromones , Cross Reactions , Cytochrome P-450 CYP3A , Cytochrome P-450 Enzyme Inhibitors , Dose-Response Relationship, Drug , ERG1 Potassium Channel , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacology , Ether-A-Go-Go Potassium Channels/pharmacology , Heart Rate/drug effects , Heterocyclic Compounds/chemical synthesis , Heterocyclic Compounds/pharmacology , Humans , Mice , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...